Nektar Therapeutics
NKTR
NKTR
246 hedge funds and large institutions have $2.87B invested in Nektar Therapeutics in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 108 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 32
40% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 108
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
246
Holding in Top 10
–
Calls
$14.8M
Puts
$10.9M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$8.16M | |
| 3 | +$6.26M | |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$3.48M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.26M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$11.7M | |
| 3 | -$11.1M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$8.96M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$8.29M |